Current prevention, diagnostic management and therapeutic management strategies for venous thromboembolism (VTE) almost all include an assessment of the clinical probability. Clinical decision rules (CDRs) are decision making tools using combinations of simple available clinical predictors to define a probability of an outcome which can be used in a preventative strategy, diagnostic course of action or therapeutic course of action. CDRs provide accurate and reproducible estimates of clinical outcomes. The best performing CDRs are built and validated following strict methodological standards. In this paper we critically review the use of CDRs in prevention, diagnosis and treatment of VTE and highlight those CDRs that are ready for the prime time of daily clinical use.
Related Content
Risk-prediction tool for identifying hospitalized children with predisposition for development of venous thromboembolism (VTE): Peds-Clot clinical Decision Rule (PCDR)
Risk-prediction tool for identifying hospitalized children with predisposition for development of venous thromboembolism (VTE): Peds-Clot clinical Decision Rule (PCDR)


Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens
Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens
Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer-associated venous thromboembolism during anticoagulant treatment
Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer-associated venous thromboembolism during anticoagulant treatment


Clinical Venous Thromboembolism Following Joint Surgery: Effect of Extended Thromboprophylaxis on Its Annual Frequency and Postoperative Pattern Over 22 Years
Clinical Venous Thromboembolism Following Joint Surgery: Effect of Extended Thromboprophylaxis on Its Annual Frequency and Postoperative Pattern Over 22 Years
Hospital-Associated Venous Thromboembolism in Children: Incidence and Clinical Characteristics
Hospital-Associated Venous Thromboembolism in Children: Incidence and Clinical Characteristics

Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women’s Health Initiative hormone therapy clinical trials
Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women’s Health Initiative hormone therapy clinical trials
Direct oral anticoagulants in the management of venous thromboembolism - evidence from major clinical trials
Direct oral anticoagulants in the management of venous thromboembolism - evidence from major clinical trials

The risk of venous thromboembolism, myocardial infarction, stroke, major bleeding and death in patients undergoing total hip and knee replacement: A 15-year retrospective cohort study of routine clinical practice
The risk of venous thromboembolism, myocardial infarction, stroke, major bleeding and death in patients undergoing total hip and knee replacement: A 15-year retrospective cohort study of routine clinical practice
Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism
Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients
The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients